Ginkgo Bioworks Holdings, Inc. ( DNA) - Stock Earnings
DNA Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q3 | -80.8 million USD | 38.8 million USD |
| 2025Q4 | -80.8 million USD | 33.4 million USD |
| 2026Q1 | -82.6 million USD | 19.5 million USD |
| 2026Q2 Est. | — | — |
| 2026Q3 Est. | — | — |
| 2026Q4 Est. | — | — |
DNA Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -892.9 million USD | 251.5 million USD |
| 2024 | -547.0 million USD | 227.0 million USD |
| 2025 | -312.8 million USD | 170.2 million USD |
| 2026 Est. | — | — |
DNA
Price: $8.24
52 week price:
Payout Ratio Range:
Earnings Per Share: -5.38 USD
Exchange: NYQ
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 21.0 million
Market Capitalization: 537.0 million